News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,957 Results
Type
Article (42548)
Company Profile (295)
Press Release (677114)
Multimedia
Podcasts (81)
Webinars (12)
Section
Business (210478)
Career Advice (2092)
Deals (36635)
Drug Delivery (107)
Drug Development (83066)
Employer Resources (175)
FDA (16586)
Job Trends (15417)
News (356120)
Policy (33935)
Tag
Academia (2598)
Accelerated approval (5)
Adcomms (21)
Allergies (92)
Alliances (51450)
ALS (100)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (141)
Approvals (16584)
Artificial intelligence (281)
Autoimmune disease (24)
Automation (17)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (189)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (296)
Cancer (2367)
Cardiovascular disease (189)
Career advice (1753)
Career pathing (31)
CAR-T (161)
Cell therapy (451)
Cervical cancer (20)
Clinical research (67660)
Collaboration (884)
Company closure (2)
Compensation (579)
Complete response letters (25)
COVID-19 (2663)
CRISPR (47)
C-suite (260)
Cystic fibrosis (106)
Data (2363)
Decentralized trials (2)
Denatured (29)
Depression (47)
Diabetes (279)
Diagnostics (6468)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (125)
Drug pricing (119)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (88843)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115584)
Executive appointments (763)
FDA (17998)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (788)
Gene editing (116)
Generative AI (22)
Gene therapy (334)
GLP-1 (761)
Government (4557)
Grass and pollen (5)
Guidances (167)
Healthcare (19004)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (135)
Indications (30)
Infectious disease (2809)
Inflammatory bowel disease (147)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (101)
Interviews (323)
IPO (16808)
IRA (47)
Job creations (4060)
Job search strategy (1492)
Kidney cancer (10)
Labor market (43)
Layoffs (500)
Leadership (18)
Legal (8380)
Liver cancer (77)
Lung cancer (327)
Lymphoma (161)
Machine learning (9)
Management (59)
Manufacturing (345)
MASH (80)
Medical device (13474)
Medtech (13479)
Mergers & acquisitions (20404)
Metabolic disorders (734)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (1990)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (40)
Obesity (387)
Opinion (230)
Ovarian cancer (82)
Pain (103)
Pancreatic cancer (89)
Parkinson's disease (156)
Partnered (22)
Patents (251)
Patient recruitment (117)
Peanut (49)
People (59342)
Pharmaceutical (91)
Pharmacy benefit managers (22)
Phase I (20993)
Phase II (29776)
Phase III (22299)
Pipeline (1437)
Policy (161)
Postmarket research (2654)
Preclinical (8949)
Press Release (68)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (406)
Real estate (6258)
Recruiting (67)
Regulatory (23199)
Reports (48)
Research institute (2370)
Resumes & cover letters (358)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (80)
Series A (136)
Series B (92)
Service/supplier (12)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3730)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (56)
The Weekly (50)
Vaccines (720)
Venture capitalists (42)
Weight loss (256)
Women's health (36)
Worklife (16)
Date
Today (181)
Last 7 days (1022)
Last 30 days (3375)
Last 365 days (33053)
2025 (12296)
2024 (35771)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40776)
Australia (6532)
California (6516)
Canada (2089)
China (556)
Colorado (278)
Connecticut (283)
Delaware (162)
Europe (87145)
Florida (967)
Georgia (217)
Idaho (57)
Illinois (563)
India (26)
Indiana (332)
Iowa (11)
Japan (177)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (934)
Massachusetts (4872)
Michigan (228)
Minnesota (408)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1817)
New Mexico (29)
New York (1831)
North Carolina (1013)
North Dakota (8)
Northern California (2877)
Ohio (210)
Oklahoma (14)
Oregon (39)
Pennsylvania (1448)
Puerto Rico (13)
Rhode Island (33)
South America (1163)
South Carolina (26)
South Dakota (1)
Southern California (2446)
Tennessee (107)
Texas (969)
United States (24448)
Utah (190)
Virginia (163)
Washington D.C. (64)
Washington State (577)
West Virginia (3)
Wisconsin (61)
719,957 Results for "aridis pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Press Releases
Aridis Provides Corporate Update
December 20, 2024
·
9 min read
Biotech Bay
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
Aridis Pharmaceuticals, Inc. (OTC QB: ARDS) today announced that its 2023 Annual Meeting of Stockholders (“Annual Meeting”), scheduled for Friday, December 15, 2023, was convened and adjourned, without any business being conducted, due to lack of the requisite quorum.
December 15, 2023
·
6 min read
Business
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (OTCQB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2023.
November 3, 2023
·
13 min read
Deals
Aridis Pharmaceuticals Announces $2 Million Offering
Aridis Pharmaceuticals, Inc. today announced the pricing of an offering of 10,000,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 10,000,000 shares of common stock at a combined offering price of $0.20 per share.
August 2, 2023
·
7 min read
Business
Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today reported financial and corporate results for its first quarter ended March 31, 2023.
June 8, 2023
·
14 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 12, 2025
·
5 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
May 8, 2025
·
5 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Biotech Bay
Aridis Provides Corporate Update
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
March 31, 2023
·
7 min read
1 of 71,996
Next
